Live Breaking News & Updates on Galt United Methodist Church

Stay updated with breaking news from Galt united methodist church. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Galectin Therapeutics (NASDAQ:GALT) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a research report released on Saturday morning. The brokerage issued a hold rating on the stock. Separately, HC Wainwright restated a buy rating and set a $11.00 price target on shares of Galectin Therapeutics in a report on Tuesday, August 15th. Read […] ....

Centaurus Financial Inc , Atria Wealth Solutions Inc , Financial Services Group Inc , Galectin Therapeutics Inc , Investors Services , Galectin Therapeutics , Free Report , Get Free Report , Services Group , Wealth Solutions , Street Corp , Therapeutics Inc , Galectin Therapeutics Daily , Nasdaq Galt , Initiated Coverage , Stocknews Com ,

HC Wainwright Reiterates Buy Rating for Galectin Therapeutics (NASDAQ:GALT)

HC Wainwright reissued their buy rating on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a report released on Tuesday morning, Benzinga reports. The firm currently has a $11.00 price target on the stock. HC Wainwright also issued estimates for Galectin Therapeutics’ Q3 2023 earnings at ($0.16) EPS, Q4 2023 earnings at ($0.16) EPS, […] ....

Atria Wealth Solutions Inc , Galectin Therapeutics Inc , Galectin Therapeutics Company Profile , Investors Services , Financial Services Group Inc , Centaurus Financial Inc , Galectin Therapeutics , Free Report , Services Group , Wealth Solutions , Street Corp , Get Free Report , Therapeutics Inc , Galectin Therapeutics Daily , Nasdaq Galt , Reiterated Rating , Hc Wainwright ,

Galectin Therapeutics' (GALT) Buy Rating Reiterated at HC Wainwright

Galectin Therapeutics (NASDAQ:GALT – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research note issued to investors on Tuesday, Benzinga reports. They presently have a $11.00 price objective on the stock. HC Wainwright also issued estimates for Galectin Therapeutics’ Q3 2023 earnings at ($0.16) EPS, Q4 […] ....

Citadel Advisors , Centaurus Financial Inc , Benjaminf Edwards Company Inc , Galectin Therapeutics Inc , Galectin Therapeutics Company Profile , Galectin Therapeutics , Get Free Report , Trail Advisors , Jane Street Group , Therapeutics Inc , Galectin Therapeutics Daily , Nasdaq Galt , Reiterated Rating , Hc Wainwright ,

HC Wainwright Reiterates Buy Rating for Galectin Therapeutics (NASDAQ:GALT)

Galectin Therapeutics (NASDAQ:GALT – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research report issued to clients and investors on Tuesday, Benzinga reports. They currently have a $11.00 target price on the stock. HC Wainwright also issued estimates for Galectin Therapeutics’ Q3 2023 earnings at ($0.16) […] ....

Northern Trust Corp , Geode Capital Management , Investors Services , Financial Services Group Inc , Galectin Therapeutics Inc , Galectin Therapeutics , Get Free Report , Trust Corp , Capital Management , Services Group , State Street Corp , Street Corp , Therapeutics Inc , Galectin Therapeutics Daily , Nasdaq Galt , Reiterated Rating , Hc Wainwright ,

Galectin Therapeutics (NASDAQ:GALT) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the stock. Galectin Therapeutics Stock Up 4.3 % Shares of NASDAQ GALT traded up $0.06 during trading on Thursday, hitting $1.45. The company had a trading […] ....

Benjaminf Edwards Company Inc , Centaurus Financial Inc , Galectin Therapeutics Inc , Galectin Therapeutics Company Profile , Citadel Advisors , Galectin Therapeutics , Free Report , Get Free Report , Trail Advisors , Jane Street Group , Therapeutics Inc , Galectin Therapeutics Daily , Nasdaq Galt , Initiated Coverage , Stocknews Com ,